Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Fortis

    Tag: fortis

    You Searched For "Fortis"
    Manipal bid to buyout Medanta for Rs 5800 crore: Report

    Manipal bid to buyout Medanta for Rs 5800 crore: Report

    Garima29 April 2019 12:20 PM IST
    MUMBAI: Cardiologist Naresh Trehan owned Medanta buyout is likely to conclude as TPG and Temasek-backed Manipal Hospitals has recently submitted a...
    Ranbaxy Case: Singh Brothers diverted funds despite SC orders, alleges Daiichi

    Ranbaxy Case: Singh Brothers diverted funds despite SC orders, alleges Daiichi

    Medical Dialogues Bureau12 April 2019 2:30 PM IST
    "Their nearly Rs 6,300 crore has been syphoned off by some 'baba'. These children have been duped," Kapil Sibal had said, adding that let the...
    Manipal-TPG exclusive agreement period expires; KKR initiates bid for Medanta: Report

    Manipal-TPG exclusive agreement period expires; KKR initiates bid for Medanta: Report

    Garima7 April 2019 4:00 PM IST
    Mumbai: Joining the fray to get a stake in the Gurugram based Medanta Medicity , US based investor firm KKR recent made a bid According to a recent...
    Singh Brothers booked under IPC 420 for Rs 2397 crore fraud

    Singh Brothers booked under IPC 420 for Rs 2397 crore fraud

    Meghna A Singhania29 March 2019 2:56 PM IST
    New Delhi: Erstwhile promoters of Religare Enterprises Limited (REL), Malvinder Mohan Singh and Shivinder Mohan Singh have been booked by the Delhi...
    NATHEALTH appoints Manipal Health Enterprise Chairman Dr Sudarshan Ballal as president for 2019-20

    NATHEALTH appoints Manipal Health Enterprise Chairman Dr Sudarshan Ballal as president for 2019-20

    Meghna A Singhania23 March 2019 1:31 PM IST
    Manipal Health ChairmanSudarshan Ballal succeeds Fortis Healthcare's Daljit Singh as the president, the Healthcare Federation of India (NATHEALTH)...
    Malvinder Singh alleges spiritual guru invested Ranbaxy stake sale proceeds to buy real estate

    Malvinder Singh alleges spiritual guru invested Ranbaxy stake sale proceeds to buy real estate

    Garima16 March 2019 1:27 PM IST
    Malvinder Singh alleged that Dhillon invested the funds in commercial properties, including a prime 260,000 sq. ft land in Delhi (near the Select City...
    Supreme court directs former Ranbaxy promoters to appear on March 14

    Supreme court directs former Ranbaxy promoters to appear on March 14

    Garima28 Feb 2019 9:30 AM IST
    "The court would like to have the personal presence of respondent nos. 2 and 4 (Malvinder and Shivinder Singh) in SLP(C) No... along with their...
    Fortis Healthcare petitions SEBI seeking arrest of Singh brothers

    Fortis Healthcare petitions SEBI seeking arrest of Singh brothers

    Farhat Nasim26 Feb 2019 11:02 AM IST
    On January 18, 2019, the SEBI deadline for notices to pay back money to Fortis expired and on February 13, 2019, a petition was filed by Fortis with...
    Fortis Brothers Feud: Malvinder accuses brother Shivinder of death threats, files criminal complaint

    Fortis Brothers Feud: Malvinder accuses brother Shivinder of death threats, files criminal complaint

    Farhat Nasim18 Feb 2019 11:46 AM IST
    New Delhi: The public fight between the former billionaire brothers, Malvinder Singh and Shivinder Mohan Singh has turned all the more dramatic as the...
    TPG-Manipal enter into Exclusive talks to Acquire Medanta- Report

    TPG-Manipal enter into Exclusive talks to Acquire Medanta- Report

    Garima17 Feb 2019 10:05 AM IST
    Mumbai: After losing out on the Fortis deal, the Manipal Group backed by TPG is making moves toward acquiring Gurugram Based Medanta Medicity by...
    Narayana Hrudayalaya former MD, CEO Ashutosh Raghuvanshi joins Fortis Healthcare as new CEO

    Narayana Hrudayalaya former MD, CEO Ashutosh Raghuvanshi joins Fortis Healthcare as new CEO

    Farhat Nasim8 Feb 2019 11:59 AM IST
    New Delhi: Ex-Managing Director(MD) and Group CEO of Narayana Hrudayalaya, Ashutosh Raghuvanshi has been appointed as the new Chief Executive...
    Fortis completes acquisition of RHT assets at enterprise value of Rs 4650 crore

    Fortis completes acquisition of RHT assets at enterprise value of Rs 4650 crore

    Farhat Nasim16 Jan 2019 1:13 PM IST
    In February last year, Fortis had announced that it has entered into definitive agreements with RHT to acquire entire portfolio of assets of the...
    PrevNext

    Popular Stories

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok